OpenVSafe by OpenVAERS
Search V-safe

ECR-23963-22801

2 vaccinations 2 coded responses 5 check-ins 2 free-text entries 0 call cases
Sex
—
Age at first dose
21-25
ZIP prefix
452 / OH
Registered
2021-04-04
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-03
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-04
    Registered in v-safe
  3. 2021-04-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  4. 2021-04-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  5. 2021-04-22
    Dose 2 — Pfizer-BioNTech
  6. 2021-05-08
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  7. 2021-06-08
    Survey response — day 42, dose 2
    MedDRA: Condition aggravated, Decreased appetite, Fatigue, Haemorrhage, Headache, Hypoglycaemia, Increased tendency to bruise, Myalgia, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: More frequent headaches, bouts of severe fatigue. Poor appetite & worsening [Pre.Ex.] alexithymia, sometimes leading to mild hypoglycemic states. Bruising & bleeding more easily. Unexplained muscle pain. Trouble maintaining hydration & electrolytes.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-07-24
    Survey response — 3 months, dose 2
    MedDRA: Breast mass, Menstruation irregular — Feeling: Good · Be unable to do your normal daily activities
    Free text: Lump in breast tissue. Worsening of menstrual cycle; symptoms, flow, irregular length/onset of cycles. It should be noted that Ive been on testosterone for over a year and had stopped menstruating for several months prior to receiving the vaccine.
    MedDRA releases: 2021-09,2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-04-03Pfizer-BioNTech
22021-04-22Pfizer-BioNTech

Free text

Release 8 — day 42, dose 2

2021-06-08

Symptoms: More frequent headaches, bouts of severe fatigue. Poor appetite & worsening [Pre.Ex.] alexithymia, sometimes leading to mild hypoglycemic states. Bruising & bleeding more easily. Unexplained muscle pain. Trouble maintaining hydration & electrolytes. cut off by CDC

Release 9 — 3 months, dose 2

2021-07-24

Symptoms: Lump in breast tissue. Worsening of menstrual cycle; symptoms, flow, irregular length/onset of cycles. It should be noted that Ive been on testosterone for over a year and had stopped menstruating for several months prior to receiving the vaccine.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBreast mass ✓ · ✓
SDCondition aggravated ✓ ✓ ✓
SDDecreased appetite ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHaemorrhage ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHypoglycaemia ✓ ✓ ✓
SDIncreased tendency to bruise ✓ ✓ ✓
SDMenstruation irregular ✓ · ✓
SDMyalgia ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release